1st International Symposium on Down Syndrome and Leukaemia: From basic mechanisms to clinical advances

17 November 2022

1st International Symposium on Down Syndrome and Leukaemia: From basic mechanisms to clinical advances

6-7 October 2022. Paris, France Last October, the Jérôme Lejeune Foundation had the pleasure to co-organise and host in our headquarters in Paris, the 1st International […]
22 February 2022

CBS, H2S and Down Syndrome: new results and new perspectives

The idea that a disequilibrium between homocysteine catabolism and the production the cysteine underlies some of the alterations observed in Down syndrome (DS) was suggested by […]
2 November 2021

Silencing the extra chromosome 21 in Down syndrome cells

Down syndrome (DS), caused by the complete or partial triplication of chromosome 21, presents a great challenge for research, medical care and development of therapies in […]
17 May 2021

Down syndrome: a molecule that targets cognitive impairments enters the decisive phase of clinical trials

Significant headway has been made in recent years to understand the causes of intellectual disability in people with Down syndrome, but therapeutic research on this syndrome […]